Pfizer, Astellas revise two cancer drug trial protocols to speed up results

Drugmakers Pfizer Inc and Astellas Pharma Inc  said on Wednesday they would change protocols for two late-stage trials testing prostate cancer drug Xtandi to speed up completion.